Structure-activity relationship homology (SARAH): A conceptual framework for drug discovery in the genomic era

Chemistry and Biology

Volumn 6, Issue 1, 1999, Pages

  Frye, Stephen V ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032802397     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(99)80013-1     Document Type: Note

References (6)

1. Kauvar, L.M., et al., & Rocke, D.M. (1995). Predicting ligand binding to proteins by affinity fingerprinting. Chem. Biol. 2, 107-118.
2. Lefkowitz, R.J., Hoffman, B.B. & Taylor, P. (1990). Neurohumoral transmission: The autonomic and somatic motor nervous systems. In Goodman and Gilman's the Pharmacological Basis of Therapeutics. (Gilman, A.G., Rall, T.W., Nies, A.S., Taylor, P., eds), Pergamon Press, New York.
3. Lehman, J., et al., & Williamson, R. (1996). Systematization of research. Nature Supp. 384, 5.
4. Jasny, B.R. & Hines, P.J. (1998). A genome sampler. Science 282, 651.
5. Toledo, L.M. & Lydon, N.B. (1997). Structures of staurosporine bound to CDK2 and cAPK - New tools for structure-based design of protein kinase inhibitors. Structure 5, 1551-1556.
6. Schreiber, S.L. (1998). Chemical genetics resulting from a passion for synthetic organic chemistry. Bioorg. Med. Chem. 6, 1127-1152.